Recruiting nowPhase 2Ages 12 Years and up
Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)
Sponsor: Jonsson Comprehensive Cancer Center · NCT06436612 on ClinicalTrials.gov ↗
Conditions studied
Abdominopelvic Sarcomas
What it tests
- Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapyradiation
Where it's running1 site
- Recruiting now
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California 90095
- Vincent Basehart(contact)3102678954[email protected]
- Christine Palodichuk(contact)3107942971[email protected]
- Vishruth Reddy, MD(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Histologically confirmed sarcoma * Primary or recurrent disease involving the abdomen or pelvis * Resectable primary lesion * Age ≥ 12 years old * Karnofsky performance status (KPS) ≥ 70 or Eastern Cooperative Oncology Group (ECOG) 0-2 * If a woman is of childbearing potential, a negative serum or urine pregnancy test must be documented Exclusion Criteria: * Active treatment of a separate malignancy * History of prior irradiation to the area targeted for treatment
Updated 2026-06-05 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.